{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T12:43:20Z","timestamp":1792932200897,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T00:00:00Z","timestamp":1727913600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CHEST"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.chest.2024.09.031","type":"journal-article","created":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T13:01:08Z","timestamp":1728478868000},"page":"736-745","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Peak Inspiratory Flow and Inhaler Prescription Strategies in a Specialized COPD Clinical Program"],"prefix":"10.1016","volume":"167","author":[{"given":"Sarah","family":"Pankovitch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Frohlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1171-3463","authenticated-orcid":false,"given":"Bader","family":"AlOthman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9711-1687","authenticated-orcid":false,"given":"Jeffrey","family":"Marciniuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanie","family":"Bernier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1299-2518","authenticated-orcid":false,"given":"Dorcas","family":"Paul-Emile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7649-038X","authenticated-orcid":false,"given":"Jean","family":"Bourbeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9974-7216","authenticated-orcid":false,"given":"Bryan A.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chest.2024.09.031_bib1","series-title":"Global Initiative for Chronic Obstructive Lung Disease website","article-title":"Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease","year":"2024"},{"key":"10.1016\/j.chest.2024.09.031_bib2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2147\/COPD.S319511","article-title":"Measuring peak inspiratory flow in patients with chronic obstructive pulmonary disease","volume":"17","author":"Ohar","year":"2022","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.chest.2024.09.031_bib3","doi-asserted-by":"crossref","DOI":"10.1177\/1753466619884532","article-title":"What to consider before prescribing inhaled medications: a pragmatic approach for evaluating the current inhaler landscape","volume":"13","author":"Lavorini","year":"2019","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.chest.2024.09.031_bib4","first-page":"232","article-title":"Canadian Thoracic Society position statement on climate change and choice of inhalers for patients with respiratory disease","volume":"5","author":"Gupta","year":"2023","journal-title":"Can J Respir Crit Care Sleep Med"},{"issue":"6","key":"10.1016\/j.chest.2024.09.031_bib5","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.rmed.2011.01.005","article-title":"Inhaler mishandling remains common in real life and is associated with reduced disease control","volume":"105","author":"Melani","year":"2011","journal-title":"Respir Med"},{"issue":"2","key":"10.1016\/j.chest.2024.09.031_bib6","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01794-2016","article-title":"Chronic obstructive pulmonary disease exacerbation and inhaler device handling: real-life assessment of 2935 patients","volume":"49","author":"Molimard","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.chest.2024.09.031_bib7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2147\/COPD.S117196","article-title":"The use of multiple respiratory inhalers requiring different inhalation techniques has an adverse effect on COPD outcomes","volume":"12","author":"Bosnic-Anticevich","year":"2016","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"9","key":"10.1016\/j.chest.2024.09.031_bib8","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1007\/s12325-022-02231-0","article-title":"Fluticasone furoate\/umeclidinium\/vilanterol (FF\/UMEC\/VI) triple therapy compared with other therapies for the treatment of COPD: a network meta-analysis","volume":"39","author":"Ismaila","year":"2022","journal-title":"Adv Ther"},{"key":"10.1016\/j.chest.2024.09.031_bib9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2147\/COPD.S424497","volume":"19","author":"Bogart","year":"2024","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.chest.2024.09.031_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1147985","article-title":"Comparison of treatment persistence, adherence, and risk of exacerbation in patients with COPD treated with single-inhaler versus multiple-inhaler triple therapy: a prospective observational study in China","volume":"14","author":"Lin","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.chest.2024.09.031_bib11","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.2147\/COPD.S370540","article-title":"Comparative adherence and persistence of single- and multiple-inhaler triple therapies among patients with chronic obstructive pulmonary disease in an English real-world primary care setting","volume":"17","author":"Halpin","year":"2022","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"2","key":"10.1016\/j.chest.2024.09.031_bib12","doi-asserted-by":"crossref","first-page":"00950","DOI":"10.1183\/23120541.00950-2020","article-title":"INTREPID: single-versus multiple-inhaler triple therapy for COPD in usual clinical practice","volume":"7","author":"Halpin","year":"2021","journal-title":"ERJ Open Res"},{"issue":"5","key":"10.1016\/j.chest.2024.09.031_bib13","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.chest.2023.08.014","article-title":"2023 Canadian Thoracic Society guideline on pharmacotherapy in patients with stable COPD","volume":"164","author":"Bourbeau","year":"2023","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.chest.2024.09.031_bib14","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.chest.2023.11.011","article-title":"Consideration and assessment of patient factors when selecting an inhaled delivery system in COPD","volume":"165","author":"Mahler","year":"2024","journal-title":"Chest"},{"key":"10.1016\/j.chest.2024.09.031_bib15","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2147\/COPD.S195438","article-title":"Prevalence and factors associated with suboptimal peak inspiratory flow rates in COPD","volume":"14","author":"Ghosh","year":"2019","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"12","key":"10.1016\/j.chest.2024.09.031_bib16","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1164\/rccm.201901-0005LE","article-title":"Peak inspiratory flow rate: an emerging biomarker in chronic obstructive pulmonary disease","volume":"199","author":"Mahler","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.chest.2024.09.031_bib17","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1183\/09031936.94.07010069","article-title":"Lung deposition of budesonide inhaled via Turbuhaler: a comparison with terbutaline sulphate in normal subjects","volume":"7","author":"Borgstr\u00f6m","year":"1994","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.chest.2024.09.031_bib18","first-page":"321","article-title":"Nebulized versus dry powder long-acting muscarinic antagonist bronchodilators in patients with COPD and suboptimal peak inspiratory flow rate","volume":"6","author":"Mahler","year":"2019","journal-title":"Chronic Obstr Pulm Dis"},{"issue":"2","key":"10.1016\/j.chest.2024.09.031_bib19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1089\/jamp.2013.1038","article-title":"Comparison of dry powder versus nebulized beta-agonist in patients with COPD who have suboptimal peak inspiratory flow rate","volume":"27","author":"Mahler","year":"2014","journal-title":"J\u00a0Aerosol Med Pulm Drug Deliv"},{"issue":"8","key":"10.1016\/j.chest.2024.09.031_bib20","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1513\/AnnalsATS.201611-903OC","article-title":"Suboptimal inspiratory flow rates are associated with chronic obstructive pulmonary disease and all-cause readmissions","volume":"14","author":"Loh","year":"2017","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.chest.2024.09.031_bib21","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2147\/COPD.S353441","article-title":"Prospective evaluation of exacerbations associated with suboptimal peak inspiratory flow among stable outpatients with COPD","volume":"17","author":"Mahler","year":"2022","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"3","key":"10.1016\/j.chest.2024.09.031_bib22","first-page":"217","article-title":"Prevalence of low peak inspiratory flow rate at discharge in patients hospitalized for COPD exacerbation","volume":"4","author":"Sharma","year":"2017","journal-title":"Chronic Obstr Pulm Dis"},{"issue":"3","key":"10.1016\/j.chest.2024.09.031_bib23","first-page":"427","article-title":"High prevalence of suboptimal peak inspiratory flow in hospitalized patients with COPD: a real-world study","volume":"9","author":"Mahler","year":"2022","journal-title":"Chronic Obstr Pulm Dis"},{"key":"10.1016\/j.chest.2024.09.031_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2019.105857","article-title":"The role of inspiratory flow in selection and use of inhaled therapy for patients with chronic obstructive pulmonary disease","volume":"161","author":"Mahler","year":"2020","journal-title":"Respir Med"},{"key":"10.1016\/j.chest.2024.09.031_bib26","series-title":"R: A Language and Environment for Statistical Computing","year":"2023"},{"key":"10.1016\/j.chest.2024.09.031_bib27","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.2147\/COPD.S380736","article-title":"Suboptimal peak inspiratory flow and critical inhalation errors are associated with higher COPD-related healthcare costs","volume":"17","author":"Leving","year":"2022","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"1","key":"10.1016\/j.chest.2024.09.031_bib28","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41533-022-00282-y","article-title":"Factors associated with health status and exacerbations in COPD maintenance therapy with dry powder inhalers","volume":"32","author":"Kocks","year":"2022","journal-title":"NPJ Prim Care Respir Med"},{"issue":"7","key":"10.1016\/j.chest.2024.09.031_bib29","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1513\/AnnalsATS.202202-131VP","article-title":"Small devices, big problems: addressing the global warming potential of metered-dose inhalers","volume":"19","author":"Rabin","year":"2022","journal-title":"Ann Am Thorac Soc"},{"issue":"3","key":"10.1016\/j.chest.2024.09.031_bib30","first-page":"00722","article-title":"High use of short-acting \u03b22-agonists in COPD is associated with an increased risk of exacerbations and mortality","volume":"9","author":"Christer","year":"2023","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.chest.2024.09.031_bib31","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2147\/COPD.S11474","article-title":"Inspiratory flows through dry powder inhaler in chronic obstructive pulmonary disease: age and gender rather than severity matters","volume":"5","author":"Malmberg","year":"2010","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.chest.2024.09.031_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105298","article-title":"Prevalence and predictors of suboptimal peak inspiratory flow rate in COPD patients","volume":"147","author":"Harb","year":"2020","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"10.1016\/j.chest.2024.09.031_bib33","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3390\/biomedicines10020458","article-title":"Relationship between peak inspiratory flow and patient and disease characteristics in individuals with COPD: a systematic scoping review","volume":"10","author":"Leving","year":"2022","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.chest.2024.09.031_bib34","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01499-2021","article-title":"ERS\/ATS technical standard on interpretive strategies for routine lung function tests","volume":"60","author":"Stanojevic","year":"2022","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.chest.2024.09.031_bib35","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1183\/09031936.00080312","article-title":"Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations","volume":"40","author":"Quanjer","year":"2012","journal-title":"Eur Respir J"}],"container-title":["CHEST"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369224052905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369224052905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T20:13:28Z","timestamp":1749845608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369224052905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0012369224052905"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2024.09.031","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peak Inspiratory Flow and Inhaler Prescription Strategies in a Specialized COPD Clinical Program","name":"articletitle","label":"Article Title"},{"value":"CHEST","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2024.09.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc under license from the American College of Chest Physicians.","name":"copyright","label":"Copyright"}]}}